These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21190937)

  • 1. Evidence that the thyroid-stimulating hormone (TSH) receptor transmembrane domain influences kinetics of TSH binding to the receptor ectodomain.
    Chen CR; McLachlan SM; Rapoport B
    J Biol Chem; 2011 Feb; 286(8):6219-24. PubMed ID: 21190937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into thyroid-stimulating autoantibody interaction with the thyrotropin receptor N-terminus based on mutagenesis and re-evaluation of ambiguity in this region of the receptor crystal structure.
    Hamidi S; Chen CR; McLachlan SM; Rapoport B
    Thyroid; 2011 Sep; 21(9):1013-20. PubMed ID: 21834684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rearrangement of the Extracellular Domain/Extracellular Loop 1 Interface Is Critical for Thyrotropin Receptor Activation.
    Schaarschmidt J; Nagel MBM; Huth S; Jaeschke H; Moretti R; Hintze V; von Bergen M; Kalkhof S; Meiler J; Paschke R
    J Biol Chem; 2016 Jul; 291(27):14095-14108. PubMed ID: 27129207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tyrosine residue on the TSH receptor stabilizes multimer formation.
    Latif R; Michalek K; Morshed SA; Davies TF
    PLoS One; 2010 Feb; 5(2):e9449. PubMed ID: 20195479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.
    Chazenbalk GD; Pichurin P; Chen CR; Latrofa F; Johnstone AP; McLachlan SM; Rapoport B
    J Clin Invest; 2002 Jul; 110(2):209-17. PubMed ID: 12122113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of mutations involving cysteine residues distal to the S281HCC motif at the C-terminus on the functional characteristics of a truncated ectodomain-only thyrotropin receptor anchored on glycosylphosphatidyl-inositol.
    Ho SC; Goh SS; Li S; Khoo DH; Paterson M
    Thyroid; 2008 Dec; 18(12):1313-9. PubMed ID: 18976165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deleting the Redundant TSH Receptor C-Peptide Region Permits Generation of the Conformationally Intact Extracellular Domain by Insect Cells.
    Chen CR; Salazar LM; McLachlan SM; Rapoport B
    Endocrinology; 2015 Jul; 156(7):2732-8. PubMed ID: 25860033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folding-dependent binding of thyrotropin (TSH) and TSH receptor autoantibodies to the murine TSH receptor ectodomain.
    Vlase H; Matsuoka N; Graves PN; Magnusson RP; Davies TF
    Endocrinology; 1997 Apr; 138(4):1658-66. PubMed ID: 9075728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High affinity binding of thyrotropin (TSH) and thyroid-stimulating autoantibody for the TSH receptor extracellular domain.
    Nagayama Y; Takeshita A; Luo W; Ashizawa K; Yokoyama N; Nagataki S
    Thyroid; 1994; 4(2):155-9. PubMed ID: 7919997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of the thyrotrophin receptor extracellular domain as a glycosylphosphatidylinositol-anchored membrane protein and its interaction with thyrotrophin and autoantibodies.
    Da Costa CR; Johnstone AP
    J Biol Chem; 1998 May; 273(19):11874-80. PubMed ID: 9565613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrotropin Receptor: Allosteric Modulators Illuminate Intramolecular Signaling Mechanisms at the Interface of Ecto- and Transmembrane Domain.
    Marcinkowski P; Kreuchwig A; Mendieta S; Hoyer I; Witte F; Furkert J; Rutz C; Lentz D; Krause G; Schülein R
    Mol Pharmacol; 2019 Oct; 96(4):452-462. PubMed ID: 31399504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for negative cooperativity among human thyrotropin receptors overexpressed in mammalian cells.
    Chazenbalk GD; Kakinuma A; Jaume JC; McLachlan SM; Rapoport B
    Endocrinology; 1996 Nov; 137(11):4586-91. PubMed ID: 8895321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thyrotropin receptor hinge region as a surrogate ligand: identification of loci contributing to the coupling of thyrotropin binding and receptor activation.
    Chen CR; Salazar LM; McLachlan SM; Rapoport B
    Endocrinology; 2012 Oct; 153(10):5058-67. PubMed ID: 23002040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone- and antibody-mediated activation of the thyrotropin receptor.
    Duan J; Xu P; Luan X; Ji Y; He X; Song N; Yuan Q; Jin Y; Cheng X; Jiang H; Zheng J; Zhang S; Jiang Y; Xu HE
    Nature; 2022 Sep; 609(7928):854-859. PubMed ID: 35940204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-dependent inhibition of oligomerization at the human thyrotropin receptor.
    Latif R; Graves P; Davies TF
    J Biol Chem; 2002 Nov; 277(47):45059-67. PubMed ID: 12223484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel TSH interaction sites by systematic binding analysis of the TSHR hinge region.
    Mueller S; Szkudlinski MW; Schaarschmidt J; Günther R; Paschke R; Jaeschke H
    Endocrinology; 2011 Aug; 152(8):3268-78. PubMed ID: 21628383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that the thyrotropin receptor protease is membrane-associated and is not within lipid rafts.
    Latrofa F; Chazenbalk GD; McLachlan SM; Rapoport B
    Thyroid; 2004 Oct; 14(10):801-5. PubMed ID: 15588374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-affinity binding of thyrotropin to the extracellular domain of its receptor transfected in Chinese hamster ovary cells.
    Shi Y; Zou M; Parhar RS; Farid NR
    Thyroid; 1993; 3(2):129-33. PubMed ID: 8396480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships.
    Szkudlinski MW; Fremont V; Ronin C; Weintraub BD
    Physiol Rev; 2002 Apr; 82(2):473-502. PubMed ID: 11917095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design.
    Zhang M; Tong KP; Fremont V; Chen J; Narayan P; Puett D; Weintraub BD; Szkudlinski MW
    Endocrinology; 2000 Sep; 141(9):3514-7. PubMed ID: 10965926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.